What Viyash Lifesciences does
Founded in 2019, Viyash Lifesciences operates in Health Tech offering an integrated pharmaceutical portfolio with niche APIs and advanced intermediates. The company runs ten manufacturing facilities with a capacity exceeding 2000 KL, serving both regulated and semi-regulated markets. With a robust R&D infrastructure comprising three facilities and over 160 scientists, Viyash focuses on multiple therapeutic areas including ARV, CV, CNS, and Oncology. The companys mission is anchored in high quality and cost efficiency, driving its research and manufacturing capabilities.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about Viyash Lifesciences yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.